StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis IFRS Operating Income Margin by Quarter

IFRS Operating Income Margin (%) (%)

QuarterlyAnnual

Novartis IFRS Operating Income Margin: 12.7% in Q3 2026, down 19.7 pts from a year earlier. That is the lowest of the 16 quarters on record here.

Latest, Q3 2026
12.7%
Period ended Sep 30, 2026
Change on a year earlier
-19.7 pts
32.4% in Q3 2025
History
16 quarters
Since Q4 2022
Sources
12
Documents cited below

Where the Q3 2026 figure comes from

“|| % of net sales | 12.7 | 32.4 | 25.8 | 34.1”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIFRS Operating Income Margin (%) (%)Year on yearSource
Q3 2026Sep 30, 202612.7%-19.7 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202633.0%-1.6 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202632.3%-2.9 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202527.1%+0.3 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202532.4%+4.1 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 202534.6%+2.5 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 202535.2%+6.7 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 202426.8%+4.2 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 202428.3%+13.3 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 202432.1%+7.6 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 202428.5%+4.3 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 202322.6%+6.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 202315.0%–Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 202324.5%–Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 202324.2%–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 202216.6%–Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis IFRS Operating Income Margin (%), quarterly Q4 2022–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/ifrs-operating-margin-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.